Literature DB >> 7152041

The activation segment of procarboxypeptidase A from porcine pancreas constitutes a folded structural domain.

F X Avilés, B S Segundo, M Vilanova, C M Cuchillo, C Turner.   

Abstract

The controlled action of trypsin on porcine pancreatic procarboxypeptidase A releases a large activation peptide which contains the activation segment of the proenzyme. Circular dichroism studies indicate that the isolated activation peptide contains a high percentage of residues in ordered secondary structures (mainly alpha-helix). This result agrees with predictions of secondary structure carried out on the published amino acid sequence of the homologous rat proenzyme. Moreover, proton magnetic resonance spectroscopy shows that the peptide adopts a thermostable tertiary structure with characteristics typical of globular proteins. The results as a whole indicate that the activation segment of porcine pancreatic procarboxypeptidase A constitutes a folded structural domain.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7152041     DOI: 10.1016/0014-5793(82)81112-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Morphology of the procarboxypeptidase A-S6 complex. A solution X-ray scattering study.

Authors:  B Kerfelec; C Chapus; P Vachette
Journal:  Eur Biophys J       Date:  1988       Impact factor: 1.733

2.  1H-n.m.r. studies of the isolated activation segment from pig procarboxypeptidase A.

Authors:  J Vendrell; F X Avilés; M Vilanova; C H Turner; C Crane-Robinson
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

3.  Analysis of the conformation and ligand-binding properties of the activation segment of pig procarboxypeptidase A.

Authors:  M Vilanova; J Vendrell; C M Cuchillo; F X Avilés
Journal:  Biochem J       Date:  1988-05-01       Impact factor: 3.857

4.  The NMR structure of the activation domain isolated from porcine procarboxypeptidase B.

Authors:  J Vendrell; M Billeter; G Wider; F X Avilés; K Wüthrich
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.